Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Washington, DC: The National Academies Press
To investigate the genetic basis of this variability, here we conduct a genome-wide association study of self-reported weight loss and treatment-related side effects in 27,885 people following GLP1 receptor agonist therapy
180 StevensR.PageD.GoubleB.GarcheryC.ZamirD.CausseM
Also, these patients are more prone to severe anemia when exposed to certain chemicals or drugs
Furthermore, metabolic stressors, such as hypercholesterolemia, have been reported to promote BBB disruption, with increased permeability and decreased claudin-5 and occludin transcription (de Oliveira et al., 2020)
US$ 26.85
US$ 21.32
US$ 26.48
US$ 25.09
